Technical Articles

Lipid metabolism
PCSK9抑制剂在缺血性卒中防治中的研究进展
Research Progress of PCSK9 Inhibitors in the Prevention and Treatment of Ischemic Stroke
发布时间 2026-02-28
Proprotein convertase subtilisin/kexin type 9, as a key molecule regulating cholesterol metabolism, has garnered significant attention in recent years.
View details
  • Cardiovascular
  • PCSK9-LDLR TR-FRET Assay Kit
  • Ischemic stroke
  • Lipid metabolism
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.